The polycystic ovarian syndrome treatment global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Polycystic Ovarian Syndrome Treatment Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The polycystic ovarian syndrome treatment market size has grown strongly in recent years. It will grow from $4.49 billion in 2023 to $4.74 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to increased awareness, advances in medical technology, lifestyle changes, pharmaceutical innovations, government initiatives.
The polycystic ovarian syndrome treatment market size is expected to see strong growth in the next few years. It will grow to $6.19 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to personalized medicine, telemedicine and remote monitoring, research and development, rising prevalence, supportive regulatory environment. Major trends in the forecast period include holistic approach, patient-centered care, digital health solutions, multidisciplinary care, patient education.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/polycystic-ovarian-syndrome-treatment-global-market-report
Scope Of Polycystic Ovarian Syndrome Treatment Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Polycystic Ovarian Syndrome Treatment Market Overview
Market Drivers –
The global rise in genetic and hormonal disorders is a key factor driving the growth of the polycystic ovarian syndrome (PCOS) treatment market. PCOS is a prevalent hormonal disorder among premenopausal women worldwide, with reproductive, endocrine, and metabolic abnormalities. The PCOS prevalence ranges from 2.2% to 26% globally and is highly variable. In China, the figures range between 2% to 7.5% and 6.3% in Sri Lanka, 9.13% in south India and 22.5% in Maharashtra. The rise in genetic and hormonal disorders globally is expected to increase the growth of the polycystic ovarian syndrome treatment market.
Market Trends –
Laparoscopic ovarian drilling is a major trend driving the growth of the polycystic ovarian syndrome treatment market. Laparoscopic ovarian drilling is a surgical treatment performed by doctors in critical conditions that can cause ovulation in women with polycystic ovary syndrome (PCOS). Ovarian drilling is often used by women with PCOS who often do not ovulate despite having attempted weight loss and the use of fertility drugs. According to a 2021 study published on Taylor and Francis online, an American open access journal, the efficacy of ovarian drilling was variable in different literature. Ovulation and pregnancy rates were found to be 30%-90% and 13%-80% respectively.
The polycystic ovarian syndrome treatment market covered in this report is segmented –
1) By Drug Type: Oral Contraceptives, Ornithine Decarboxylase Inhibitors, Insulin-Sensitizing Agents, Anti-Depressants, Diuretics, Aromatase Inhibitors
2) By Surgery Type: Ovarian Wedge Resection, Laparoscopic Ovarian Drilling
3) By End User: Hospitals & Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Gynecology Centers, Feminist Health Centers
Get an inside scoop of the polycystic ovarian syndrome treatment market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=2827&type=smp
Regional Insights –
North America was the largest region in the polycystic ovarian syndrome treatment market in 2023. Western Europe was the second largest region in the polycystic ovarian syndrome treatment market. The regions covered in the polycystic ovarian syndrome treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Key Companies –
Major companies operating in the polycystic ovarian syndrome treatment market include Bristol-Myer Squibb Co, Bayer AG, Pfizer Inc., Merck KGaA, Sanofi SA, AstraZeneca PLC, Novartis AG, Teva Pharmaceutical Industries Limited, Abbott Laboratories, Addex Therapeutics Ltd., BIOCAD, Allergan plc., Johnson and Johnson, Ferring Pharmaceuticals Inc., Takeda Pharmaceutical Company Limited, Organon & Co, Forendo Pharma Ltd., GlaxoSmithKline plc, AbbVie Inc., Eli Lilly and Company, Mylan NV, Lupin Pharmaceuticals Inc., HRA Pharma SAS, CooperSurgical Inc., TherapeuticsMD Inc., Agile Therapeutics Inc., OvaScience Inc., Aurobindo Pharma Limited, Sun Pharmaceutical Industries Ltd., Zydus Cadila Healthcare Limited, Glenmark Pharmaceuticals Limited
Table of Contents
1. Executive Summary
2. Polycystic Ovarian Syndrome Treatment Market Report Structure
3. Polycystic Ovarian Syndrome Treatment Market Trends And Strategies
4. Polycystic Ovarian Syndrome Treatment Market – Macro Economic Scenario
5. Polycystic Ovarian Syndrome Treatment Market Size And Growth
…..
27. Polycystic Ovarian Syndrome Treatment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
